Rejuvant leads longevity pack with significant biologic age reduction

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

A recent release by Ponce De Leon Health outlines findings from a large-scale longevity study presented at a Nutritional Business Journal CEO conference, according to the company. The analysis, using AI-driven cross-sectional modeling adjusted for age, sex, smoking and health status, examined 4,260 individuals who purchased saliva-based DNA epigenetic tests between 2020 and 2025 and reported using nearly 900 different longevity products.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oura spends $625m to put doctors behind its smart ring

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE